BATS BZX Real-Time Price
As of 2:55pm ET
| +0.07 / +0.44%|
The 4 analysts offering 12-month price forecasts for Vanda Pharmaceuticals Inc have a median target of 22.50, with a high estimate of 24.00 and a low estimate of 19.00. The median estimate represents a +41.51% increase from the last price of 15.90.
The current consensus among 4 polled investment analysts is to Buy stock in Vanda Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.